ICD-10-CM Billable Code

B42.0

Pulmonary sporotrichosis

Clinical Classification Guidelines

Medical Intelligence & Overview

Pulmonary sporotrichosis is a rare fungal infection that affects the lungs. It is caused by the fungus Sporothrix schenckii, which typically enters the body through inhalation of spores. This condition is classified under ICD-10 code B42.0 and primarily occurs in individuals with weakened immune systems or those exposed to environments where the fungus is prevalent. Recognizing the signs and understanding the causes of pulmonary sporotrichosis can aid in timely diagnosis and management.

Causes & Symptoms

Clinical Causes: Inhalation of spores from the Sporothrix schenckii fungus, often present in soil, plant material, or organic matter. Environmental exposure during activities such as gardening, farming, or handling decaying vegetation. Pre-existing immune suppression which reduces the body’s ability to fight off fungal infections. Rarely, spores can be transmitted via inhalation from contaminated agricultural or gardening equipment.

Key Symptoms: Persistent cough that may produce sputum or blood Chest pain, often sharp or stabbing in nature Shortness of breath or wheezing Fever and chills Fatigue and malaise Unintended weight loss over time Night sweats

Diagnostic & Treatment

Diagnosis Path: Diagnosis of pulmonary sporotrichosis involves a combination of clinical evaluation and laboratory testing. Physicians may recommend imaging studies such as chest X-rays or CT scans to identify lung abnormalities. Microbiological examinations, including sputum cultures and tissue biopsies, are utilized to detect Sporothrix schenckii. In some cases, serological tests or molecular methods like PCR may be used to support diagnosis. Medical history focusing on environmental exposure and immune status also plays a vital role.

Treatment Protocols: Treatment strategies for pulmonary sporotrichosis typically involve antifungal medications. The most common medications include itraconazole, which is administered orally over several months. In severe or resistant cases, amphotericin B may be prescribed. Monitoring treatment progress with follow-up imaging and laboratory tests is essential. Rest and supportive care, such as managing symptoms and maintaining adequate nutrition, can also support recovery. Early diagnosis and consistent treatment are key to preventing complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B42.0 a billable ICD-10 code?
Yes, B42.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B42.0?
Clinical documentation must specify the nature of Pulmonary sporotrichosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

sporotrichosis pulmonary